All Stories

  1. Glucagon-like peptide-1 medicines in neurological and psychiatric disorders

    Article • Cell Reports Medicine, December 2025, Elsevier

    Daniel Drucker

  2. The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications

    Article • Diabetes, August 2018, American Diabetes Association

    Daniel Drucker

  3. Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling

    Article • Stem Cells International, January 2018, Hindawi Publishing Corporation

    Daniel Drucker

  4. β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation

    Article • Diabetes, March 2017, American Diabetes Association

    Daniel Drucker

  5. Glucagon, GLP-1, GLP-2, GIP-Actions on blood vessels

    Article • Endocrine Reviews, December 2016, Endocrine Society

    Daniel Drucker

  6. Evolving Concepts and Translational Relevance of Enteroendocrine Cell Biology

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2016, Endocrine Society

    Daniel Drucker

  7. Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors

    Article • Endocrine Reviews, December 2014, Endocrine Society

    Daniel Drucker